{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:12:53Z","timestamp":1786990373632,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["K08 GM140310-01"],"award-info":[{"award-number":["K08 GM140310-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","award":["2018011890"],"award-info":[{"award-number":["2018011890"]}],"id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ijantimicag.2023.106913","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T12:31:07Z","timestamp":1688646667000},"page":"106913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Addition of aminoglycosides reduces recurrence of infections with multidrug-resistant Gram-negative bacilli in patients with sepsis and septic shock"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-9804","authenticated-orcid":false,"given":"M. Cristina Vazquez","family":"Guillamet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Damulira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Micek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-0751","authenticated-orcid":false,"given":"Marin H.","family":"Kollef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106913_bib0001","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0002","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","article-title":"A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic\/meta-regression study","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0003","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","article-title":"Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0004","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1128\/AAC.00115-10","article-title":"Influence of empiric therapy with a \u03b2-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to Gram-negative microorganisms","volume":"54","author":"Mart\u00ednez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.020","article-title":"\u03b2-Lactam antibiotic versus combined \u03b2-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: a meta-analysis","volume":"55","author":"Heffernan","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0006","article-title":"\u03b2 Lactam antibiotic monotherapy versus \u03b2 lactam\u2013aminoglycoside antibiotic combination therapy for sepsis","volume":"2014","author":"Paul","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0007","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/j.1875-9114.1995.tb04366.x","article-title":"Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies","volume":"15","author":"Fish","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3476(99)70197-6","article-title":"Comparison of a \u03b2-lactam alone versus \u03b2-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis","volume":"134","author":"Smith","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/430912","article-title":"Effect of aminoglycoside and \u03b2-lactam combination therapy versus \u03b2-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials","volume":"41","author":"Bliziotis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.abg9868","article-title":"Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections","volume":"375","author":"Stracy","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0011","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/cid\/ciz1206","article-title":"Impact of baseline characteristics on future episodes of bloodstream infections: multistate model in septic patients with bloodstream infections","volume":"71","author":"Guillamet","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0012","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0013","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0014","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine\u2013Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cmi.2020.10.016","article-title":"Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review","volume":"27","author":"Palacios-Baena","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2018.01.029","article-title":"Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli","volume":"53","author":"Falcone","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0017","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1469-0691.2011.03658.x","article-title":"Clinical characteristics of bacteraemia caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type \u03b2-lactamases","volume":"18","author":"Qureshi","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0018","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations","volume":"193","author":"Fleischmann","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0019","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.2015.1410","article-title":"Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions","volume":"313","author":"Prescott","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archinte.1989.00390060033007","article-title":"Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis","volume":"149","author":"Gerecht","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0021","doi-asserted-by":"crossref","first-page":"e39435","DOI":"10.7554\/eLife.39435","article-title":"The distribution of antibiotic use and its association with antibiotic resistance","volume":"7","author":"Olesen","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0022","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/432056","article-title":"Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals","volume":"41","author":"MacDougall","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0023","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ijantimicag.2004.09.009","article-title":"Only percentage within species; neither incidence, nor prevalence: demographic information and representative surveillance data are urgently needed to estimate the burden of antimicrobial resistance","volume":"24","author":"Monnet","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0024","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/383309","article-title":"Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997\u20132001","volume":"38","author":"Bergman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0025","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41396-019-0344-9","article-title":"Van den Bergh B, Michiels J. Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates","volume":"13","author":"Windels","year":"2019","journal-title":"ISME J"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0026","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-019-1521-8","article-title":"Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut","volume":"573","author":"Bakkeren","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0027","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1574-6976.2011.00295.x","article-title":"Emergence and spread of antibiotic resistance following exposure to antibiotics","volume":"35","author":"Cant\u00f3n","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2023.106913_bib0028","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/AAC.44.9.2485-2491.2000","article-title":"Concentration-dependent selection of small phenotypic differences in TEM \u03b2-lactamase-mediated antibiotic resistance","volume":"44","author":"Negri","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923001929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923001929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:45:29Z","timestamp":1760377529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923001929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0924857923001929"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106913","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of aminoglycosides reduces recurrence of infections with multidrug-resistant Gram-negative bacilli in patients with sepsis and septic shock","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106913"}}